Mobile poultry vending and slaughtering of sick poultry have been linked to the spread of highly pathogenic avian influenza (HPAI) H5N1 in Bangladesh. However, limited data exist on associated practices and potential interventions to improve biosecurity among mobile poultry vendors. This mixed-method study was conducted in three phases across four sub-districts in Bangladesh. In phase 1, researchers conducted 416 hours of structured observation, 40 in-depth interviews with poultry vendors, and 40 informal interviews with the customers. Phase 2 involved the development and pilot testing of an intervention package, which included poultry slaughtering cones, hand sanitizers, disinfectants, and a hygiene pamphlet, with 10 vendors. Phase 3 implemented the full intervention with 20 vendors, followed by 94 hours of observation and 17 customer interviews. At baseline, vendors sourced poultry from multiple locations, kept them in small cages on rickshaw vans, and slaughtered them in open spaces, drains, or near water sources. Waste was often discarded in the environment or fed to animals. Vendors demonstrated limited hygiene knowledge and were not observed using personal protective equipment, soap, or disinfectants. Post-intervention, vendors adopted improved practices such as using killing cones, containing waste, disinfecting the slaughtering area, and cleaning hands before eating. Customers also viewed the intervention positively. The study highlights significant risks of AIV transmission through mobile poultry vending but demonstrates that low-cost, targeted interventions can enhance hygiene and biosecurity. Further research is needed to assess long-term sustainability and scalability.

The authors have declared no competing interest.

The author(s) received no specific funding for this work.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We obtained written informed consent from study participants. The study protocol was reviewed and approved by the Institutional Review Boards at icddr,b.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data cannot be shared publicly because of ethical restrictions related to participant confidentiality and informed consent. Data are available from the icddr,b Institutional Data Access/Ethics Committee (contact via email ) for researchers who meet the criteria for access to confidential data.